Alzheimer's Disease
Showing NaN - NaN of 87
Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)
Not yet recruiting
- Alzheimer's Disease
- GSK4527226
- Placebo
-
San Diego, California
- +99 more
Oct 6, 2023
Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)
Completed
- Alzheimer's Disease
- PF-04360365 0.1 mg/kg
- +5 more
-
Peoria, Arizona
- +41 more
Oct 11, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)
Recruiting
- Alzheimer's Disease
- Placebo
- Bepranemab
-
Sun City, Arizona
- +115 more
Aug 18, 2022
Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)
Recruiting
- Alzheimer's Disease
- Remternetug (IV)
- +2 more
-
Chandler, Arizona
- +70 more
Aug 10, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)
Alzheimer's Disease Trial in United States (TB006, Placebo)
Active, not recruiting
- Alzheimer's Disease
- TB006
- Placebo
-
Garden Grove, California
- +17 more
May 29, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Alzheimer's Disease Trial in Delray Beach, Miami (Longeveron Mesenchymal Stem Cells, Placebo)
Completed
- Alzheimer's Disease
- Longeveron Mesenchymal Stem Cells
- Placebo
-
Delray Beach, Florida
- +2 more
Dec 13, 2021
Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Phoenix, Arizona
- +180 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)
Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)
Alzheimer's Disease Trial in Worldwide (Elenbecestat, Placebo)
Agitation Associated With, Alzheimer's Disease, Alzheimer's Type Trial in Worldwide (Brexpiprazole, OPC-34712, Placebo Oral
Completed
- Agitation Associated With
- +4 more
- Brexpiprazole, OPC-34712
- Placebo Oral Tablet
-
Tuscaloosa, Alabama
- +84 more
Dec 8, 2020
Agitation Associated With, Alzheimer's Disease, Alzheimer's Type Trial in Worldwide (Brexpiprazole, OPC-34712)
Completed
- Agitation Associated With
- +4 more
- Brexpiprazole, OPC-34712
-
Imperial, California
- +70 more
Nov 4, 2020
Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)
Completed
- Alzheimer's Disease
- Flortaucipir F18
- PET Scan
-
Phoenix, Arizona
- +30 more
Sep 3, 2020
Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
- Placebo
-
Tucson, Arizona
- +31 more
Jul 31, 2020